| Valerie Willis, DO | |
|
317 N Mission St Ste 200, Wenatchee, WA 98801-2072 | |
| (509) 663-8711 | |
| Not Available |
| Full Name | Valerie Willis |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
| Location | 317 N Mission St Ste 200, Wenatchee, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942652540 | NPI | - | NPPES |
| Entity Name | Central Washington Health Services Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801937453 PECOS PAC ID: 4880504596 Enrollment ID: O20031106000287 |
News Archive
"Bake sales saved the nonprofit Athol Memorial Hospital the first time around, Steve Penka says with a smile. Eleven years later, it took a big Tennessee-based, for-profit hospital chain to keep it in business," the (Worcester, Mass.) Telegram & Gazette reports. In light of a recent report by Massachusetts Attorney General Martha Coakley's office, many are surprised Athol is around at all.
Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 pivotal trials for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH).
Pharmasset, Inc. and Roche have announced that the first patient has been dosed in a Phase IIb study of R7128, the nucleoside polymerase inhibitor most advanced in development for the treatment of chronic hepatitis C (HCV).
Research led by Dr. Nicolas Bazan, Boyd Professor, Villere Chair, and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center, has shown that Docosahexaenoic acid (DHA), a component of fish oil, is a powerful therapeutic agent that can protect brain tissue and promote recovery in an experimental model of acute ischemic stroke, even when treatment is delayed by up to five hours.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Valerie Willis, DO 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 663-8711 | Valerie Willis, DO 317 N Mission St Ste 200, Wenatchee, WA 98801-2072 Ph: (509) 663-8711 |
News Archive
"Bake sales saved the nonprofit Athol Memorial Hospital the first time around, Steve Penka says with a smile. Eleven years later, it took a big Tennessee-based, for-profit hospital chain to keep it in business," the (Worcester, Mass.) Telegram & Gazette reports. In light of a recent report by Massachusetts Attorney General Martha Coakley's office, many are surprised Athol is around at all.
Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 pivotal trials for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH).
Pharmasset, Inc. and Roche have announced that the first patient has been dosed in a Phase IIb study of R7128, the nucleoside polymerase inhibitor most advanced in development for the treatment of chronic hepatitis C (HCV).
Research led by Dr. Nicolas Bazan, Boyd Professor, Villere Chair, and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center, has shown that Docosahexaenoic acid (DHA), a component of fish oil, is a powerful therapeutic agent that can protect brain tissue and promote recovery in an experimental model of acute ischemic stroke, even when treatment is delayed by up to five hours.
› Verified 6 days ago
Dr. James Brockbank Johnson, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 246 N Mission St, Wenatchee, WA 98801 Phone: 509-662-1955 Fax: 509-662-6695 | |
Dr. Richard Lynn, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 246 N Mission St, Wenatchee, WA 98801 Phone: 509-662-1955 Fax: 509-662-6695 |